A detailed history of Lindbrook Capital, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 240 shares of CDMO stock, worth $2,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
240
Previous 303 20.79%
Holding current value
$2,966
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$6.7 - $12.45 $422 - $784
-63 Reduced 20.79%
240 $2,000
Q2 2024

Jul 31, 2024

BUY
$6.34 - $9.28 $399 - $584
63 Added 26.25%
303 $2,000
Q4 2023

Jan 31, 2024

BUY
$4.64 - $9.56 $1,113 - $2,294
240 New
240 $1,000
Q3 2023

Oct 25, 2023

SELL
$9.4 - $14.04 $235 - $351
-25 Closed
0 $0
Q2 2023

Jul 28, 2023

BUY
$12.96 - $20.93 $324 - $523
25 New
25 $0
Q3 2022

Nov 10, 2022

BUY
$15.33 - $20.36 $383 - $509
25 New
25 $0

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $768M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.